DYRK1A and cancer: Although DYRK1B has an overall protumorigenic role specifically in pancreatic and ovarian cancers, DYRK1A exhibits a more controversial role with reports of both protumorigenic and antitumorigenic mechanism in different cancers (reviewed in Boni et al. [8]).